These findings were consistent with the results in our study that the overexpression of CXCR4, CXCL10, and S100A12, and the decreased PPP3R1 and HSP90AB1 might be predictive for poor prognosis of AD patients. Here, CXCL10 is linked to Alzheimer disease.